Investing

Managing Director Resignation and Board Changes

December 29, 2025
Investing

Jeffrey Christian: Gold, Silver at Record Prices, Expect Spikes Higher in 2026

December 28, 2025
Investing

Rick Rule, Ed Steer, Vince Lanci and More — Our Top 5 Interviews of the Year

December 28, 2025
Investing

Biotech Market Forecast: Top Trends for Biotech in 2026

December 25, 2025
Investing

What is the Santa Claus Rally and Has it Arrived?

December 25, 2025
Investing

Craig Hemke: Silver, Gold’s “Outstanding” Year — Will 2026 Bring a Repeat?

December 25, 2025
Home Investing RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202
Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

You may also like

Nickel Price Update: Q2 2025 in Review

July 29, 2025

Altech Batteries LtdCerenergy Battery Project Funding Progressing Well

July 23, 2025

Silver Reserves: Top 5 Countries

May 29, 2025

Providence Gold Mines Inc. Announces Financing Update on...

September 13, 2025

Results of Entitlement Offer

June 24, 2025

BSX Secures JV Partner & Funding for Ta...

August 27, 2025

Locksley Qualifies for Trading on U.S. OTCQX Market

October 13, 2025

Variation to Noteholder Agreements

May 22, 2025

Crypto Market Update: Bitcoin Price Logs Weakest Month...

November 22, 2025

Heliostar Metals

November 28, 2025